Jeffrey N. Carey

Jeffrey N. Carey

Auto-generated profile, based on publicly available information

Jeffrey N. Carey

Graduate Group in Biochemistry and Molecular Biophysics, Perelman School of Medicine University of Pennsylvania Philadelphia Pennsylvania USA

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2010 in Molecular Cell
Verified
Journal Article
Closed access
PSParisha P. Shah
Parisha P. Shah
XZXiuzhong Zheng
Xiuzhong Zheng
AEAnastasiya Epshtein
Anastasiya Epshtein
JCJeffrey N. Carey
Jeffrey N. Carey
DBDouglas K. Bishop
Douglas K. Bishop
HKHannah L. Klein
Hannah L. Klein

29 July 2016 in Nature Communications
Verified
Journal Article
Open access
SYSrujana S. Yadavalli
Srujana S. Yadavalli
JCJeffrey N. Carey
Jeffrey N. Carey
RLRachel S. Leibman
Rachel S. Leibman
ACAnnie I. Chen
Annie I. Chen
ASAndrew M. Stern
Andrew M. Stern
MGMark Goulian
Mark Goulian
Antimicrobial peptides are an important component of the molecular arsenal employed by hosts against bacteria. Many bacteria in turn possess pathways that provide protection against these compounds. In Escherichia coli and related bacteria, the PhoQ/PhoP signalling system is a key regulator of this antimicrobial peptide defence. Here we show that treating E. coli with sublethal concentrations of antimicrobial peptides causes cells to filament, and that this division block is controlled by the PhoQ/PhoP system. The filamentation results from increased expression of QueE, an enzyme that is part of a tRNA modification pathway but that, as we show here, also affects cell division. We also find that a functional YFP–QueE fusion localizes to the division septum in filamentous cells, suggesting QueE blocks septation through interaction with the divisome. Regulation of septation by PhoQ/PhoP may protect cells from antimicrobial peptide-induced stress or other conditions associated with high-level stimulation of this signalling system.

1 March 2018 in Cell
Verified
Journal Article
Closed access
JCJeffrey N. Carey
Jeffrey N. Carey
EMErin L. Mettert
Erin L. Mettert
MRManuela Roggiani
Manuela Roggiani
KMKevin Myers
Kevin Myers
PKPatricia J. Kiley
Patricia J. Kiley
MGMark Goulian
Mark Goulian

20 June 2009 in Applied Microbiology and Biotechnology
Verified
Journal Article
Closed access
PDF file
SYSukhwan Yoon
Sukhwan Yoon
JCJeffrey N. Carey
Jeffrey N. Carey
JSJeremy D. Semrau
Jeremy D. Semrau

1 August 2008 in Journal of Inorganic Biochemistry
Verified
Journal Article
Closed access
DCDong W. Choi
Dong W. Choi
JSJeremy D. Semrau
Jeremy D. Semrau
WAWilliam E. Antholine
William E. Antholine
SHScott C. Hartsel
Scott C. Hartsel
RARyan C. Anderson
Ryan C. Anderson
ADAlan A. DiSpirito
Alan A. DiSpirito

25 October 2019 in eLife
Verified
Journal Article
Open access
JCJeffrey N Carey
Jeffrey N Carey
EMErin L Mettert
Erin L Mettert
DFDaniel R Fishman-Engel
Daniel R Fishman-Engel
MRManuela Roggiani
Manuela Roggiani
PKPatricia J Kiley
Patricia J Kiley
MGMark Goulian
Mark Goulian
Temperate bacteriophages are viruses that can incorporate their genomes into their bacterial hosts, existing there as prophages that refrain from killing the host cell until induced. Prophages are largely quiescent, but they can alter host phenotype through factors encoded in their genomes (often virulence factors) or by disrupting host genes as a result of integration. Here we describe another mechanism by which a prophage can modulate host phenotype. We show that a temperate phage that integrates in Escherichia coli reprograms host regulation of an anaerobic respiratory system, thereby inhibiting a bet hedging strategy. The phage exerts this effect by upregulating a host-encoded signal transduction protein through transcription initiated from a phage-encoded promoter. We further show that this phenomenon occurs not only in a laboratory strain of E. coli, but also in a natural isolate that contains a prophage at this site.